Home
/
AYTU BIOPHARMA, INC
/
Financials
/
Quarterly
AYTU BIOPHARMA, INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that AYTU BIOPHARMA, INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Mar 31, 2021
$13.48M
May 17, 2021
Q2
2021
Dec 31, 2020
$15.15M
Feb 11, 2021
Q1
2021
Sep 30, 2020
$13.52M
Nov 12, 2020
Q3
2021
Mar 31, 2020
$8.16M
May 17, 2021
Q2
2021
Dec 31, 2019
$3.18M
Feb 11, 2021
Q1
2021
Sep 30, 2019
$1.44M
Nov 12, 2020
Q3
2020
Mar 31, 2019
$2.38M
May 15, 2020
Q2
2020
Dec 31, 2018
$1.80M
Feb 14, 2020
Q1
2020
Sep 30, 2018
$1.43M
Nov 14, 2019
Q3
2019
Mar 31, 2018
$607.5K
May 14, 2019
Q2
2019
Dec 31, 2017
$1.05M
May 14, 2019
Q1
2019
Sep 30, 2017
$1.08M
Nov 7, 2018
Q3
2018
Mar 31, 2017
$893.5K
May 14, 2018
Q2
2018
Dec 31, 2016
$794.2K
Feb 8, 2018
Q1
2018
Sep 30, 2016
$698.0K
Nov 9, 2017
Q3
2017
Mar 31, 2016
$668.5K
May 11, 2017
Q2
2017
Dec 31, 2015
$469.2K
Feb 9, 2017
Q1
2017
Sep 30, 2015
$487.4K
Nov 7, 2016
Q3
2016
Mar 31, 2015
$23.8K
May 11, 2016
Q2
2016
Dec 31, 2014
$28.3K
Feb 11, 2016
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$15.17M
Feb 3, 2026
Q1
2026
Sep 30, 2025
$13.89M
Nov 13, 2025
Q3
2025
Mar 31, 2025
$18.45M
May 14, 2025
Q2
2026
Dec 31, 2024
$16.22M
Feb 3, 2026
Q1
2026
Sep 30, 2024
$16.57M
Nov 13, 2025
Q3
2025
Mar 31, 2024
$14.03M
May 14, 2025
Q2
2025
Dec 31, 2023
$18.75M
Feb 12, 2025
Q1
2025
Sep 30, 2023
$17.82M
Nov 13, 2024
Q3
2024
Mar 31, 2023
$22.73M
May 15, 2024
Q2
2024
Dec 31, 2022
$26.28M
Feb 14, 2024
Q1
2024
Sep 30, 2022
$27.66M
Nov 14, 2023
Q3
2023
Mar 31, 2022
$24.20M
May 11, 2023
Q2
2023
Dec 31, 2021
$23.13M
Feb 21, 2023
Q1
2023
Sep 30, 2021
$21.90M
Feb 21, 2023
Q3
2022
Mar 31, 2021
$13.48M
May 16, 2022
Q2
2022
Dec 31, 2020
$15.15M
Feb 14, 2022
Q1
2022
Sep 30, 2020
$13.52M
Nov 15, 2021
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Mar 31, 2018
$607.5K
May 14, 2018
Q2
2018
Dec 31, 2017
$1.05M
Feb 8, 2018
Q1
2018
Sep 30, 2017
$1.08M
Nov 9, 2017
Q3
2018
Mar 31, 2017
$893.5K
May 14, 2018
Q2
2018
Dec 31, 2016
$794.2K
Feb 8, 2018
Q1
2018
Sep 30, 2016
$698.0K
Nov 9, 2017
Q3
2017
Mar 31, 2016
$647.0K
May 11, 2017
Q2
2017
Dec 31, 2015
$448.0K
Feb 9, 2017
Q1
2017
Sep 30, 2015
$466.0K
Nov 7, 2016
Q3
2016
Mar 31, 2015
$2.0K
May 11, 2016
Q2
2016
Dec 31, 2014
$7.0K
Feb 11, 2016
Q1
2015
Sep 30, 2014
$6.0K
Nov 6, 2015
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
($10.58M)
Feb 3, 2026
Q1
2026
Sep 30, 2025
$1.97M
Nov 13, 2025
Q2
2026
Sep 30, 2025
$1.97M
Feb 3, 2026
Q3
2025
Mar 31, 2025
$3.99M
May 14, 2025
Q3
2025
Dec 31, 2024
$788.0K
May 14, 2025
Q2
2026
Dec 31, 2024
$788.0K
Feb 3, 2026
Q2
2026
Sep 30, 2024
$1.47M
Feb 3, 2026
Q1
2026
Sep 30, 2024
$1.47M
Nov 13, 2025
Q3
2025
Sep 30, 2024
$1.47M
May 14, 2025
Q3
2025
Mar 31, 2024
($2.89M)
May 14, 2025
Q2
2025
Dec 31, 2023
($220.0K)
Feb 12, 2025
Q3
2025
Dec 31, 2023
($220.0K)
May 14, 2025
Q3
2025
Sep 30, 2023
($8.12M)
May 14, 2025
Q1
2025
Sep 30, 2023
($8.12M)
Nov 13, 2024
Q2
2025
Sep 30, 2023
($8.12M)
Feb 12, 2025
Q3
2024
Mar 31, 2023
($7.20M)
May 15, 2024
Q2
2024
Dec 31, 2022
($6.69M)
Feb 14, 2024
Q3
2024
Dec 31, 2022
($6.69M)
May 15, 2024
Q3
2024
Sep 30, 2022
($701.0K)
May 15, 2024
Q2
2024
Sep 30, 2022
($701.0K)
Feb 14, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
($1.97M)
Feb 3, 2026
Q1
2026
Sep 30, 2025
($1.50M)
Nov 13, 2025
Q3
2025
Mar 31, 2025
$2.42M
May 14, 2025
Q2
2026
Dec 31, 2024
($1.70M)
Feb 3, 2026
Q1
2026
Sep 30, 2024
($930.0K)
Nov 13, 2025
Q3
2025
Mar 31, 2024
($1.60M)
May 14, 2025
Q2
2025
Dec 31, 2023
$3.15M
Feb 12, 2025
Q1
2025
Sep 30, 2023
($867.0K)
Nov 13, 2024
Q3
2024
Mar 31, 2023
($8.56M)
May 15, 2024
Q2
2024
Dec 31, 2022
($6.87M)
Feb 14, 2024
Q1
2024
Sep 30, 2022
($1.81M)
Nov 14, 2023
Q3
2023
Mar 31, 2022
($53.42M)
May 11, 2023
Q2
2023
Dec 31, 2021
($11.29M)
Feb 21, 2023
Q1
2023
Sep 30, 2021
($27.70M)
Feb 21, 2023
Q3
2022
Mar 31, 2021
($25.67M)
May 16, 2022
Q2
2022
Dec 31, 2020
($5.58M)
Feb 14, 2022
Q1
2022
Sep 30, 2020
($3.56M)
Nov 15, 2021
Q3
2021
Mar 31, 2020
($4.79M)
May 17, 2021
Q2
2021
Dec 31, 2019
($4.97M)
Feb 11, 2021
Q1
2021
Sep 30, 2019
($4.74M)
Nov 12, 2020